Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	410.38	403.82	434.22	470.78	662.21	660.67
Short-Term Investments	1,212	1,203	1,356	399.14	328.91	453.97
Cash & Short-Term Investments	1,622	1,607	1,791	869.92	991.12	1,115
Cash Growth	-7.76%	-10.25%	105.84%	-12.23%	-11.08%	31.94%
Accounts Receivable	461.94	489.02	494.65	423.54	419.42	392.67
Other Receivables	11.1	11.9	11.6	2.2	1.4	2
Receivables	473.04	500.92	506.25	425.74	420.82	394.67
Inventory	804.28	780.52	719.32	572.24	622.25	554.01
Prepaid Expenses	133.23	140.04	124.18	109.14	90.62	102.33
Restricted Cash	1.38	0.15	0.01	0.01	3.99	0.09
Other Current Assets	21.24	19.56	17.55	13.44	11.03	14.41
Total Current Assets	3,056	3,048	3,158	1,990	2,140	2,180
Property, Plant & Equipment	719.17	723.74	679.56	716.44	693.51	701.21
Long-Term Investments	6,001	7,697	8,830	14,386	9,560	4,638
Goodwill	415.1	413.57	406.49	347.34	291.92	264.13
Other Intangible Assets	307.33	320.51	332.15	253.94	199.5	145.53
Other Long-Term Assets	105.12	96.35	95.8	105.49	87.82	79.64
Total Assets	10,603	12,299	13,502	17,799	12,973	8,009
Accounts Payable	122.19	144.63	135.04	141.94	139.45	107.01
Accrued Expenses	146.02	139.93	194.79	312.97	256.93	207.61
Current Portion of Long-Term Debt	0.76	-	-	-	1.3	425.67
Current Portion of Leases	43.33	40.87	36.8	36.92	37.01	35.87
Current Income Taxes Payable	43.63	35.76	32.43	10.32	23.28	8.76
Current Unearned Revenue	-	-	-	50.85	42.47	33.74
Other Current Liabilities	142.01	161.62	169.65	127.94	131.1	86.84
Total Current Liabilities	497.94	522.8	568.71	680.94	631.54	905.5
Long-Term Debt	1,191	1,189	1,188	0	1.26	2.38
Long-Term Leases	153.22	175.09	163.73	186.45	186.13	187.22
Long-Term Deferred Tax Liabilities	1,076	1,475	1,770	3,065	2,077	997.79
Other Long-Term Liabilities	197.63	135.61	150.61	108.39	102.17	80.52
Total Liabilities	3,116	3,558	3,886	4,114	3,093	2,254
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	448.33	449.08	447.45	441.73	429.38	410.02
Retained Earnings	8,132	9,261	9,898	13,525	9,268	5,471
Treasury Stock	-777.43	-632.54	-263.59	-106.29	-99.91	-38.4
Comprehensive Income & Other	-315.27	-336.04	-466.82	-175.55	282.46	-87.35
Shareholders' Equity	7,488	8,741	9,615	13,685	9,880	5,755
Total Liabilities & Equity	10,603	12,299	13,502	17,799	12,973	8,009
Total Debt	1,388	1,405	1,388	223.38	225.69	651.13
Net Cash (Debt)	234.38	201.75	402.56	646.54	765.43	463.51
Net Cash Growth	-33.70%	-49.88%	-37.74%	-15.53%	65.14%	14.34%
Net Cash Per Share	8.25	6.91	13.52	21.40	25.38	15.36
Filing Date Shares Outstanding	28	28.52	29.6	29.93	29.84	29.93
Total Common Shares Outstanding	28	28.52	29.6	29.93	29.84	29.93
Working Capital	2,558	2,526	2,589	1,310	1,508	1,275
Book Value Per Share	267.46	306.51	324.89	457.20	331.05	192.31
Tangible Book Value	6,765	8,007	8,877	13,084	9,389	5,345
Tangible Book Value Per Share	241.66	280.77	299.93	437.12	314.59	178.62
Land	-	28.4	27.8	27.94	25.74	25.22
Buildings	-	419.8	393.6	385.8	363.05	341.6
Machinery	-	1,148	1,087	1,100	1,064	1,015

Source: S&P Capital IQ. Standard template. Financial Sources.